Neuroprotective effect of ghrelin is associated with decreased expression of prostate apoptosis response-4

Endocrine Journal

Volumn 56, Issue 4, 2009, Pages 609-617

  Hwang, Sunyoung ^a   Moon, Minho ^a   Kim, Sehee ^a   Hwang, Lakkyong ^a   Ahn, Kyu Jeung ^b   Park, Seungjoon ^a  

^a Kyung Hee University Hospital   (South Korea)

^b Kyung Hee University College of Medicine   (South Korea)

Author keywords

Apoptosis; Bax; Bcl 2; Cytochrome c; Ghrelin; Neuroprotection; Prostate apoptosis response 4 (Par 4)

Indexed keywords

CASPASE 3; CYTOCHROME C; GHRELIN; PROTEIN BAX; PROTEIN BCL 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; BRAIN DAMAGE; BRAIN ISCHEMIA; CONTROLLED STUDY; ENZYME INHIBITION; GENE; GENE EXPRESSION; HISTOPATHOLOGY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; PROSTATE APOPTOSIS RESPONSE 4 GENE; RAT;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BCL-2-ASSOCIATED X PROTEIN; BRAIN ISCHEMIA; CASPASE 3; CYTOCHROMES C; GHRELIN; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; NEURONS; NEUROPROTECTIVE AGENTS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GHRELIN; REPERFUSION INJURY;

EID: 68449105015     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K09E-072     Document Type: Article

References (47)

1. Date Y, Kojima M, Hosoda H, Sawaguchi A, Mondal MS, Suganuma T, Matsukura S, Kangawa K, Nakazato M (2000) Ghrelin, a novel growth hormone-relasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 141:4255-4261. (Pubitemid 30953541)
2. Hosoda H, Kojima M, Matsuo H, Kangawa K (2000) Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue. Biochem Biophys Res Commun 279:909-913. (Pubitemid 32042875)
3. Kojima M, Kangawa K (2005) Ghrelin: structure and function. Physiol Rev 85:495-522.
4. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K (1999) Ghrelin is A Growth Hormone-relesasing acylated peptide from stomach. Nature 402:656-660. (Pubitemid 129516334)
5. Van der Lely AJ, Tschop M, Heiman ML, ghigo E (2004) Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev 25:426-457.
6. Baldanzi G, Filigheddu N, Cutrupi S, Catapano F, Bonissoni S, Fubini A, Malan D, Baj G, Granata R, Broglio F, Papotti M, Surico N, Bussolino F, Isgaard J, Deghenghi R, Sinigaglia F, Prat M, Muccioli G, Ghigo E, Graziani A (2002) Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J Cell Biol 159:1029-1037. (Pubitemid 36055757)
7. Granata R, Settanni F, Biancone L, Trovato L, Nano R, Bertuzzi F, Destefanis S, Annunziata M, Martinetti M, Catapano F, Ghe C, Isgaard J, Papotti M, Ghigo E, Muccioli G (2007) Acylated and unacylated ghrelin promote proliferation and inhibit apoptosis of pancreatic beta-cells and human islets: involvement of 3′,5′-cyclic adenosine monophosphate/protein kinase A, extracellular signal-regulated kinase 1/2, and phosphatidyl inositol 3-Kinase/Akt signaling. Endocrinology 148:512-529. (Pubitemid 46143157)
8. Cassoni P, Papotti M, Ghe C, Catapano F, Sapino A, Graziani A, Deghenghi R, Reissmann T, Ghigo E, Muccioli G (2001) Identification, characterization, and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast carcinomas and cell lines. J Clin Endocrinol Metab 86:1738-1745. (Pubitemid 32374931)
9. Cassoni P, Ghe C, Marrocco T, Tarabra E, Allia E, Catapano F, Deghenghi R, Ghigo E, Papotti M, Muccioli G (2004) Expression of ghrelin and biological activity of specific receptors for ghrelin and desacyl ghrelin in human prostate neoplasms and related cell lines. Eur J Endocrinol 150:173-184. (Pubitemid 38312810)
10. Nanzer AM, Khalaf S, Mozid AM, Fowkes RC, Patel MV, Burrin JM, Grossman AB, Korbonits M (2004) Ghrelin exerts a proliferative effect on a rat pituitary somatotroph cell line via the mitogen-activated protein kinase pathway. Eur J Endocrinol 151:233-240. (Pubitemid 39207019)
11. Delhanty PJ, van der Eerden BC, van d, V, Gauna C, Pols HA, Jahr H, Chiba H, van der Lely AJ, van Leeuwen JP (2006) Ghrelin and unacylated ghrelin stimulate human osteoblast growth via mitogen-activated protein kinase (MAPK)/phosphoinositide 3-kinase (PI3K) pathways in the absence of GHS-R1a. J Endocrinol 188:37-47.
12. Maccarinelli G, Sibilia V, Torsello A, Raimondo F, Pitto M, Giustina A, Netti C, Cocchi D (2005) Ghrelin regulates proliferation and differentiation of osteoblastic cells. J Endocrinol 184:249-256. (Pubitemid 40207579)
13. Filigheddu N, Gnocchi VF, Coscia M, Cappelli M, Porporato PE, Taulli R, Traini S, Baldanzi G, Chianale F, Cutrupi S, Arnoletti E, Ghe C, Fubini A, Surico N, Sinigaglia F, Ponzetto C, Muccioli G, Crepaldi T, Graziani A (2007) Ghrelin and Des-acyl ghrelin Promote Differentiation and Fusion of C2C12 Skeletal Muscle Cells. Mol Biol Cell 18:986-994. (Pubitemid 46399502)
14. Choi K, Roh SG, Hong YH, Shrestha YB, Hishikawa D, Chen C, Kojima M, Kangawa K, Sasaki S (2003) The role of ghrelin and growth hormone secretagogues receptor on rat adipogenesis. Endocrinology 144:754-759. (Pubitemid 36262842)
15. Mattson MP, Culmsee C, Yu ZF (2000) Apoptotic and antiapoptotic mechanisms in stroke. Cell Tissue Res 301:173-187.
16. Sells SF, Wood DP, Jr., Joshi-Barve SS, Muthukumar S, Jacob RJ, Crist SA, Humphreys S, Rangnekar VM (1994) Commonality of the gene programs induced by effectors of apoptosis in androgen-dependent and -independent prostate cells. Cell Growth Differ 5:457-466. (Pubitemid 24251397)
17. Culmsee C, Zhu Y, Krieglstein J, Mattson MP (2001) Evidence for the involvement of Par-4 in ischemic neuron cell death. J Cereb Blood Flow Metab 21:334-343. (Pubitemid 32298880)
18. Chung H, Seo S, Moon M, Park S (2007) IGF-I inhibition of apoptosis is associated with decreased expression of prostate apoptosis response-4. J Endocrinol 194:77-85. (Pubitemid 47162889)
19. Green DR, Reed JC (1998) Mitochondria and apoptosis. Science 281:1309-1312.
20. Chan PH (2004) Mitochondria and neuronal death/ survival signaling pathways in cerebral ischemia. Neurochem Res 29:1943-1949. (Pubitemid 39663875)
21. Shi Y (2001) A structural view of mitochondria-mediated apoptosis. Nat Struct Biol 8:394-401.
22. Yoshida H, Kong YY, Yoshida R, Elia AJ, Hakem A, Hakem R, Penninger JM, Mak TW (1998) apaf1 is required for mitochondrial pathways of apoptosis and brain development. Cell 94:739-750. (Pubitemid 28436006)
23. Chung H, Seo S , Moon M, Park S (2008) Phosphatidylinositol-3-kinase/akt/ glycogen synthase kinase-3 beta and ERK1/2 pathways mediate protective effects of acylated and unacylated ghrelin against oxygen-glucose deprivation-induced apoptosis in primary rat cortical neuronal cells. J Endocrinol 198:511-521.
24. Pearson G, Robinson F, Beers Gt, Xu BE, Karandikar M, Berman K, Cobb MH (2001) Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 22:153-183. (Pubitemid 32458157)
25. Datta SR, Brunet A, Greenberg ME (1999) Cellular survival: a play in three akts. Genes Dev 13:2905-2927.
26. Chung H, Kim E, Lee DH, Seo S, Ju S, Lee D, Kim H, Park S (2007) Ghrelin inhibits apoptosis in hypothalamic neuronal cells during oxygen-glucose deprivation. Endocrinology 148:148-159. (Pubitemid 46021447)
27. Miao Y, Xia Q, Hou Z, Zheng Y, Pan H, Zhu S (2007) Ghrelin protects cortical neuron against focal ischemia/ reperfusion in rats. Biochem Biophys Res Commun 359:795-800. (Pubitemid 46899020)
28. Nagasawa H, Kogure K (1989) Correlation between cerebral blood flow and histologic changes in a new rat model of middle cerebral artery occlusion. Stroke 20:1037-1043. (Pubitemid 19204017)
29. Li F, Irie K, Anwer Ms, Fisher M (1997) Delayed triphenyltetrazolium chloride staining remains useful for evaluating cerebral infarct volume in a rat stroke model. J Cereb Blood Flow Metab 17:1132-1135. (Pubitemid 27459342)
30. Banks WA, Tschop M, Robinson SM, Heiman ML (2002) Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure. J Pharmacol Exp Ther 302:822-827. (Pubitemid 34787253)
31. Date Y, Murakami N, Toshinai K, Matsukura S, Niijima A, Matsuo H, Kangawa K, Nakazato M (2002) The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology 123:1120-1128.
32. Asakawa A, Inui A, Kaga T, Yuzuriha H, Nagata T, Ueno N, Makino S, Fujimiya M, Niijima A, Fujino MA, Kasuga M (2001) Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology 120:337-345. (Pubitemid 32149296)
33. Toshinai K, Yamaguchi H, Sun Y, Smith RG, Yamanaka A, Sakurai T, Date Y, Mondal MS, Shimbara T, Kawagoe T, Murakami N, Miyazato M, Kangawa K, Nakazato M (2006) Des-acyl ghrelin induces food intake by a mechanism independent of the growth hormone secretagogue receptor. Endocrinology 147:2306-2314.
34. Duan W, Rangnekar VM, Mattson MP (1999) Prostate apoptosis response-4 production in synaptic compartments following apoptotic and excitotoxic insults: evidence for a pivotal role in mitochondrial dysfunction and neuronal degeneration. J Neurochem 72:2312-2322. (Pubitemid 29242181)
35. Chakraborty M, Qiu Sg, Vasudevan KM, Rangnekar VM (2001) Par-4 drives trafficking and activation of Fas and Fasl to induce prostate cancer cell apoptosis and tumor regression. Cancer Res 61:7255-7263. (Pubitemid 32946523)
36. Guo Q, Xie J, Chang X, Zhang X, Du H (2001) Par-4 is a synaptic protein that regulates neurite outgrowth by altering calcium homeostasis and transcription factor AP-1 activation. Brain Res 903:13-25. (Pubitemid 32904602)
37. Camandola S, Mattson MP (2000) Pro-apoptotic action of Par-4 involves inhibition of NF-kappaB activity and suppression of BCL-2 expression. J Neurosci Res 61:134-139. (Pubitemid 30451800)
38. El-guendy N, Zhao Y, Gurumurthy S, Burikhanov R, Rangnekar VM (2003) Identification of a unique core domain of par-4 sufficient for selective apoptosis induction in cancer cells. Mol Cell Biol 23:5516-5525. (Pubitemid 36951320)
39. Boghaert ER, Sells SF, Walid AJ, Malone P, Williams NM, Weinstein MH, Strange R, Rangnekar VM (1997) Immunohistochemical analysis of the proapoptotic protein Par-4 in normal rat tissues. Cell Growth Differ 8:881-890. (Pubitemid 27355461)
40. Goswami A, Ranganathan P, Rangnekar VM (2006) The phosphoinositide 3-kinase/akt1/Par-4 axis: a cancer-selective therapeutic target. Cancer Res 66:2889-2892.
41. Yuan J, Yankner BA (2000) Apoptosis in the nervous system. Nature 407:802-809.
42. Merry DE, Korsmeyer SJ (1997) Bcl-2 gene family in the nervous system. Annu Rev Neurosci 20:245-267.
43. Korsmeyer SJ (1995) Regulators of cell death. Trends Genet 11:101-105.
44. Fujimura M, Morita-Fujimura Y, Murakami K, Kawase M, Chan PH (1998) Cytosolic redistribution of cytochrome c after transient focal cerebral ischemia in rats. J Cereb Blood Flow Metab 18:1239-1247. (Pubitemid 28509838)
45. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91:479-489. (Pubitemid 27508237)
46. Zou H, Henzel WJ, Liu X, Lutschg A, Wang X (1997) Apaf-1, a human protein homologous to C. elegans Ced-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90:405-413. (Pubitemid 27347231)
47. Slee EA, Harte MT, Kluck RM, Wolf BB, Casiano CA, Newmeyer DD, Wang HG, Reed JC, Nicholson DW, Alnemri ES, Green DR, Martin SJ (1999) Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J Cell Biol 144:281-292